The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE–/–Mouse Model
- Authors: Buscemi, S; Dear, AE; Simpson, RW; Gaspari, TA; Welungoda, I; Widdop, RE; Knudsen, LM; Mancuso, M
- Publication year: 2013
- Type: eedings
- Key words: Atherosclerosis, liraglutide, plaque, mouse
- OA Link: http://hdl.handle.net/10447/84865